CYTARABINE for Diffuse large b-cell lymphoma recurrent: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 165 adverse event reports in the FDA FAERS database where CYTARABINE was used for Diffuse large b-cell lymphoma recurrent.
Most Reported Side Effects for CYTARABINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 6,142 | 13.8% | 688 | 3,869 |
| Off label use | 4,183 | 9.4% | 841 | 1,320 |
| Pyrexia | 2,992 | 6.7% | 376 | 1,948 |
| Neutropenia | 2,558 | 5.8% | 520 | 1,087 |
| Disease progression | 2,352 | 5.3% | 625 | 373 |
| Drug ineffective | 2,281 | 5.1% | 772 | 730 |
| Thrombocytopenia | 2,148 | 4.8% | 397 | 903 |
| Sepsis | 2,013 | 4.5% | 882 | 995 |
| Myelosuppression | 1,869 | 4.2% | 107 | 1,017 |
| Product use in unapproved indication | 1,619 | 3.7% | 377 | 473 |
| Pancytopenia | 1,596 | 3.6% | 295 | 722 |
| Pneumonia | 1,570 | 3.5% | 633 | 742 |
| Septic shock | 1,364 | 3.1% | 708 | 751 |
| Death | 1,357 | 3.1% | 1,357 | 124 |
| Mucosal inflammation | 1,337 | 3.0% | 178 | 625 |
Other Indications for CYTARABINE
Acute myeloid leukaemia (8,295)
Acute lymphocytic leukaemia (7,619)
Diffuse large b-cell lymphoma (3,857)
Product used for unknown indication (2,411)
Chemotherapy (1,355)
Mantle cell lymphoma (1,174)
Non-hodgkin's lymphoma (1,108)
Burkitt's lymphoma (939)
B-cell lymphoma (881)
Central nervous system lymphoma (843)
Other Drugs Used for Diffuse large b-cell lymphoma recurrent
RITUXIMAB (507)
ETOPOSIDE (174)
BENDAMUSTINE (168)
DEXAMETHASONE (162)
CYCLOPHOSPHAMIDE (144)
CISPLATIN (137)
AXICABTAGENE CILOLEUCEL (123)
TISAGENLECLEUCEL (118)
GEMCITABINE (117)
VINCRISTINE (108)